Search

everythinglearnresearchcommunity

for

Search:↓

Different types of hair loss can be caused by hormones, stress, autoimmune disorders, illness, or nutritional deficiencies, and can be treated with medication, nutritional supplements, or hair transplantation.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Younger patients with severe alopecia areata often have nail problems.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Hair follicles prevent NK cell attacks to avoid hair loss.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Inflammation damages sweat ducts, causing sweat gland injury.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

UV dermoscopy helps detect white hairs in children more effectively.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Heat treatment increases hair loss in certain mice.